Jaundice in the Intensive Care Unit

Surgical Clinics of North America

Volumn 86, Issue 6, 2006, Pages 1495-1502

  Bansal, Vishal ^a   Schuchert, Vaishali Dixit ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BILIRUBIN; CARBON MONOXIDE; CATECHOLAMINE; DOBUTAMINE; FIBRONECTIN; HEME OXYGENASE 1; NITRIC OXIDE; PHOSPHODIESTERASE INHIBITOR;

ALCOHOL CONSUMPTION; CELL PROTECTION; CLINICAL DECISION MAKING; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE MARKER; DRUG MECHANISM; EMERGENCY PHYSICIAN; ERYTHROCYTE METABOLISM; HEART FAILURE; HEMODYNAMICS; HUMAN; HYPERBILIRUBINEMIA; HYPOTENSION; INCIDENCE; INTENSIVE CARE UNIT; JAUNDICE; LIVER DISEASE; LIVER FAILURE; METABOLIC DISORDER; MORBIDITY; MULTIPLE ORGAN FAILURE; NONHUMAN; OBSTRUCTIVE JAUNDICE; PATIENT CARE; PRIORITY JOURNAL; REVIEW; SEPSIS; SHOCK; TOTAL PARENTERAL NUTRITION; TOXICOLOGY; TREATMENT PLANNING;

ANIMALS; COMORBIDITY; HUMANS; INTENSIVE CARE UNITS; JAUNDICE; JAUNDICE, OBSTRUCTIVE; MULTIPLE TRAUMA; PARENTERAL NUTRITION, TOTAL; PROGNOSIS;

EID: 33751013272     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suc.2006.09.007     Document Type: Review

References (30)

1. Hawker F. Liver dysfunction in critical illness. Anaesth Intensive Care 19 2 (1991) 165-181
2. Lillemoe K.D. Benign biliary stricture. In: Cameron J.L. (Ed). Current surgical therapy. 7th edition (2001), Mosby, Philadelphia (PA) 454-461
3. Strassburg C.P. Gastrointestinal disorders of the critically ill. Shock liver. Best Pract Res Clin Gastroenterol 17 3 (2003) 369-381
4. Brienza N., Revelly J.P., Ayuse T., et al. Effects of PEEP on liver arterial and venous blood flows. Am J Respir Crit Care Med 152 2 (1995) 504-510
5. Giallourakis C.C., Rosenberg P.M., and Friedman L.S. The liver in heart failure. Clin Liver Dis 6 4 (2002) 947-967
6. van Lingen R., Warshow U., Dalton H.R., et al. Jaundice as a presentation of heart failure. J R Soc Med 98 8 (2005) 357-359
7. Croce M.A., Fabian T.C., Menke P.G., et al. Nonoperative management of blunt hepatic trauma is the treatment of choice for hemodynamically stable patients. Results of a prospective trial. Ann Surg 221 6 (1995) 744-753
8. Labori K.J., and Raeder M.G. Diagnostic approach to the patient with jaundice following trauma. Scand J Surg 93 3 (2004) 176-183
9. Fink M.P. Hyperbilirubinemia. In: Fink M.P., Abraham E., Vincent J.-L., et al. (Eds). Textbook of critical care. 5th edition (2005), Elsevier Saunders, Philadelphia 99-100
10. Hass P. Differentiation and diagnosis of jaundice. AACN Clinical Issues: Advanced Practice in Acute Critical Care 10 4 (1999) 433-441
11. Faust T.W., and Reddy K.R. Postoperative jaundice. Clin Liver Dis 8 1 (2004) 151-166
12. Labori K.J., Bjornbeth B.A., and Raeder M.G. Aetiology and prognostic implication of severe jaundice in surgical trauma patients. Scand J Gastroenterol 38 1 (2003) 102-108
13. Bauer I., Bauer M., Pannen B.H., et al. Chronic ethanol consumption exacerbates liver injury following hemorrhagic shock: role of sinusoidal perfusion failure. Shock 4 5 (1995) 324-331
14. Gimson A.E. Hepatic dysfunction during bacterial sepsis. Intensive Care Med 13 30 (1987) 162-166
15. Pirovino M., Meister F., Rubli E., et al. Preserved cytosolic and synthetic liver function in jaundice of severe extrahepatic infection. Gastroenterology 96 (1989) 1589-1595
16. Roelofsen H., van der Veere C.N., Ottenhoff R., et al. Decreased bilirubin transport in the perfused liver of endotoxemic rats. Gastroenterology 107 (1994) 1075-1084
17. Miyaso H., Morimoto Y., Ozaki M., et al. Obstructive jaundice increases sensitivity to lipopolysaccharide via TLR4 upregulation: possible involvement in gut-derived hepatocyte growth factor-protection of hepatocytes. J Gastroenterol Hepatol 20 12 (2005) 1859-1866
18. Ito Y., Machen N.W., Urbaschek R., et al. Biliary obstruction exacerbates the hepatic microvascular inflammatory response to endotoxin. Shock 14 6 (2000) 599-604
19. Qiu Z., Kwon A., Tsuji K., et al. Fibronectin prevents D-galactosamine/lipopolysaccharide-induced lethal hepatic failure in mice. Shock 25 1 (2006) 80-87
20. Forbes A. Parenteral nutrition: new advances and observations. Curr Opin Gastroenterol 20 2 (2004) 114-118
21. Chung C., and Buchman A.L. Postoperative jaundice and total parenteral nutrition-associated hepatic dysfunction. Clin Liver Dis 6 4 (2002) 1067-1084
22. Nanji A.A., and Anderson F.H. Sensitivity and specificity of liver function tests in the detection of parenteral nutrition-associated cholestasis. JPEN J Parenter Enteral Nutr 9 3 (1985) 307-308
23. Colomb V., Jobert-Giraud A., Lacaille F., et al. Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children. JPEN J Parenter Enteral Nutr 24 6 (2000) 345-350
24. Hwang T.L., Lue M.C., and Chen L.L. Early use of cyclic TPN prevents further deterioration of liver functions for the TPN patients with impaired liver function. Hepatogastroenterology 47 35 (2000) 1347-1350
25. Kram H.B., Evans T., Bundage B., et al. Use of dobutamine for treatment of shock liver syndrome. Crit Care Med 16 6 (1988) 644-645
26. Gantner F., Kusters S., Wendel A., et al. Protection from T cell-mediated murine liver failure by phosphodiesterase inhibitors. J Pharmacol Exp Ther 280 1 (1997) 53-60
27. Saavedra J.E., Billiar T.R., Williams D.L., et al. Targeting nitric oxide (NO) delivery in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-alpha-induced apoptosis and toxicity in the liver. J Med Chem 40 (1997) 1947-1954
28. Amersi F., Buelow R., Kato H., et al. Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J Clin Invest 104 (1999) 1631-1639
29. Zuckerbraun B.S., Billiar T.R., Otterbein S.L., et al. Carbon monoxide protects against liver failure through nitric oxide-induced heme oxygenase 1. J Exp Med 198 11 (2003) 1707-1716
30. Mizuguchi T., Mitaka T., Katsuramaki T., et al. Hepatocyte transplantation for total liver repopulation. J Hepatobiliary Pancreat Surg 12 5 (2005) 378-385